News

Previously, Susvimo was called the Port Delivery System with ranibizumab in the United States

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a one-time, outpatient procedure, continuously delivering a customized formulation of ranibizumab over time.

Researchers reported identifying changes in 4 areas of the brain

Optical coherence tomography angiography (OCTA) was performed in all participants; the choroidal and retinal changes were examined and recorded.

The company states the acquisition will further MERIT’s service offerings, allowing for a seamless transition from preclinical to clinical phase of drug development.

The company offers year-round educational services on the conditions, using this month, in particular, to guide patients to needed resources.

The hearing aid glasses from EssilorLuxottica received CE marking under the Medical Devices Regulation of the EMA

OCU400 is the first gene therapy from the biotechnology company to move forward into Phase 3 with a broad retinitis pigmentosa (RP) indication

The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated for treatment of AMD.

Pavblu and Skojoy, both from Amgen, are indicated for the treatment of neovascular age-related macular degeneration

Results from the study assisted Notal Vision in receiving De Novo authorization from the US FDA for the SCANLY Home OCT in 2024.

Previous research has shown that voretigene neparvovec administered subretinally early in childhood for RPE65-mediated inherited retinal dystrophy achieved encouraging efficacious results.

Laru-zova is a gene therapy currently being investigated for the treatment of patients with X-linked retinitis pigmentosa.

The gel addresses necrotic retinal cell death in dry age-related macular degeneration and geographic atrophy without requiring injections.

The device recently received 510(k) clearance from the US Food and Drug Administration.

The main outcomes were the measurements of the visual acuity and visual field defects.

As Ophthalmology Times celebrates 50 years of publication and the Wilmer Eye Institute marks 100 years of academic leadership, Peter J. McDonnell, MD, reflects on their shared commitment to helping ophthalmologists improve patient outcomes.

Investigators examined the connection between amblyopia, components of the metabolic syndrome and individual cardiometabolic diseases.

Among these eyes, 18.9% of eyes developed nAMD within 36 months.

Previous research has shown that voretigene neparvovec administered subretinally early in childhood for RPE65-mediated inherited retinal dystrophy achieved encouraging efficacious results.

The lead gene therapy candidate, AXV-101, is expected to enter clinical development in mid-2025

The scientific outputs from MACUSTAR’s study could impact more than 200 million patients with AMD globally

Zhaoke Ophthalmology Limited is responsible for developing and obtaining regulatory approval for NVK-002 in Greater China, South Korea, and the Southeast Asian territories.

The Sentinel Camera aims to address critical gaps in retinal disease screening by offering a portable device that captures high-quality images that require no dilation of the eye.

Investigators examined the connection between amblyopia, components of the metabolic syndrome and individual cardiometabolic diseases

The program will deliver a range of high-quality access and affordability services for retina specialists.

The extension includes lenses that range from minus power of -13.00 diopters to cylindrical power up to 4.00 diopters